Lester Lee

Array ( [id] => 1270900 [patent_doc_number] => 06653312 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same' [patent_app_type] => B1 [patent_app_number] => 09/787467 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24699 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 427 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653312.pdf [firstpage_image] =>[orig_patent_app_number] => 09787467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064189 [patent_doc_number] => 20020032191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => '6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors' [patent_app_type] => new [patent_app_number] => 09/802086 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24740 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032191.pdf [firstpage_image] =>[orig_patent_app_number] => 09802086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570802 [patent_doc_number] => 06498251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Tetrahydrobenzindole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/582416 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44555 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498251.pdf [firstpage_image] =>[orig_patent_app_number] => 09582416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882895 [patent_doc_number] => 20010049367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Cyclic and bicyclic diamino histamine-3 receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/799450 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51836 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049367.pdf [firstpage_image] =>[orig_patent_app_number] => 09799450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319468 [patent_doc_number] => 06605615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Hydrazones and analogs as cholesterol lowering agents' [patent_app_type] => B2 [patent_app_number] => 09/798247 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10717 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605615.pdf [firstpage_image] =>[orig_patent_app_number] => 09798247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898826 [patent_doc_number] => 20010046991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Derivatives of quinoline as alpha-2 antagonists' [patent_app_type] => new [patent_app_number] => 09/794277 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13063 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046991.pdf [firstpage_image] =>[orig_patent_app_number] => 09794277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545525 [patent_doc_number] => 20020137736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 09/763835 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15395 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137736.pdf [firstpage_image] =>[orig_patent_app_number] => 09763835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601158 [patent_doc_number] => 06476050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-05 [patent_title] => '3-substituted piperidines comprising urea functionality, and methods of use thereof' [patent_app_type] => B2 [patent_app_number] => 09/792866 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24469 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476050.pdf [firstpage_image] =>[orig_patent_app_number] => 09792866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987346 [patent_doc_number] => 20010036946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Modified amino acids, pharmaceuticals containing these compounds and method for their production' [patent_app_type] => new [patent_app_number] => 09/789391 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95471 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036946.pdf [firstpage_image] =>[orig_patent_app_number] => 09789391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205899 [patent_doc_number] => 06716828 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage' [patent_app_type] => B1 [patent_app_number] => 09/781195 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25705 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716828.pdf [firstpage_image] =>[orig_patent_app_number] => 09781195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908320 [patent_doc_number] => 20010011087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Vitronectin receptor antagonists, their preparation and their use' [patent_app_type] => new [patent_app_number] => 09/778755 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19212 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011087.pdf [firstpage_image] =>[orig_patent_app_number] => 09778755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159169 [patent_doc_number] => 20020147230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Aminal Diones as potassium channel openers' [patent_app_type] => new [patent_app_number] => 09/778684 [patent_app_country] => US [patent_app_date] => 2001-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32588 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147230.pdf [firstpage_image] =>[orig_patent_app_number] => 09778684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1089400 [patent_doc_number] => 06828323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Isoalloxazine derivatives to neutralize biological contaminants' [patent_app_type] => B2 [patent_app_number] => 09/777727 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9557 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828323.pdf [firstpage_image] =>[orig_patent_app_number] => 09777727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210060 [patent_doc_number] => 20020072530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Indole and benzimidazole inhibitors of factor Xa' [patent_app_type] => new [patent_app_number] => 09/773383 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19155 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072530.pdf [firstpage_image] =>[orig_patent_app_number] => 09773383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033497 [patent_doc_number] => 20020019395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Indalone and benzimidazolone inhibitors of factor Xa' [patent_app_type] => new [patent_app_number] => 09/773372 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13412 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019395.pdf [firstpage_image] =>[orig_patent_app_number] => 09773372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586017 [patent_doc_number] => 06358936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => 'Compounds for the treatment of cancer' [patent_app_type] => B2 [patent_app_number] => 09/773178 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15188 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358936.pdf [firstpage_image] =>[orig_patent_app_number] => 09773178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874497 [patent_doc_number] => 20020049142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Benzazoles: benzoxazole, benzthiazole and benzimidazole derivatives' [patent_app_type] => new [patent_app_number] => 09/767880 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65731 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049142.pdf [firstpage_image] =>[orig_patent_app_number] => 09767880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697506 [patent_doc_number] => 20030109700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Carboxamides useful as inhinitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion' [patent_app_type] => new [patent_app_number] => 10/181006 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12852 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109700.pdf [firstpage_image] =>[orig_patent_app_number] => 10181006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908322 [patent_doc_number] => 20010011089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Substituted oximes and hydrazones as neurokinin antagonists' [patent_app_type] => new [patent_app_number] => 09/759045 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14237 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011089.pdf [firstpage_image] =>[orig_patent_app_number] => 09759045 [rel_patent_id] =>[rel_patent_doc_number] =>)